Business
Bionik Laboratories Provides Company Highlights
Bionik Laboratories Provides Company Highlights.
About this update from Bionik Laboratories Corp.
[{"type":"text","content":"\n\n TORONTO and BOSTON, March 09, 2017 (GLOBE NEWSWIRE) -- Bionik Laboratories Corp. (OTCQX:BNKL) (“Bionik” or the \"Company\"), a global pioneering robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological disorders, announced today the company’s recent highlights.\n Development and commercialization strategy designed to provide leading-edge robotic rehabilitation and assistive product solutions from hospital to home, representing $11 billion addressable market.Appointed Malcolm G. Bock as Vice President of Engineering.- Mr. Bock is an established and experienced leader in the development of medical devices.Appointed Bill Harris as Marketing Director, where he is responsible for implementing the brand strategy with 25 years of experience in health care products.- He is providing commercial input into product line development of the Bionik robots for health care facilities and consumer home use. Bionik products have been tested in over 240 locations in 20 countries.Focus on bringing new products to market and expanding global footprint to drive future revenue growth: - Advanced InMotion AnkleBot™ expected to be commercially available in first calendar quarter of 2018; - Launch of next generation upper body commercial product line planned in second calendar quarter of 2017; and - Negotiating with Tier-1 ODM to optimize manufacturing and distribute products in Asian markets. “Management believes that Bionik Laboratories is at an inflection point in the Company’s development,” stated Mr. Peter Bloch, Chief Executive Officer and Chairman of the Board. “The rapidly expanding marketplace coupled with ongoing advancements in the field of robotics have positioned us well in this expanding market. We have focused on building the commercial team and advancing our products in development to market. In addition, we have successfully forged relationships with some of the most respected names in the healthcare industry. We believe these achievements have provided a strong foundation for future growth.  Going forward, we intend to leverage our strategic relationships and our proven technologies to increase revenue, expand market opportunities and enhance overall shareholder value.” Bionik’s previously announced growth ...